Dual-isotope SPECT imaging of striatal dopamine: A comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 3, 2012, Pages 183-191

  Schmitt, G J E ^a   Dresel, S ^b   Frodl, T ^a   La Fougere C ^b   Boerner, R ^a   Hahn, K ^b   Moller H J ^a   Meisenzahl, E M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Haloperidol; Schizophrenia; SPET imaging; Striatal D2 receptor binding; Striatal dopamine autoreceptor (DAT) binding

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HALOPERIDOL; ILLICIT DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIOAVAILABILITY; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; DISEASE EXACERBATION; DOPAMINERGIC TRANSMISSION; DRUG BLOOD LEVEL; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HUMAN; MALE; MONOTHERAPY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIOECONOMICS; TREATMENT DURATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BENZAMIDES; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HALOPERIDOL; HUMANS; MALE; ORGANOTECHNETIUM COMPOUNDS; PROTEIN BINDING; PSYCHIATRIC STATUS RATING SCALES; PYRROLIDINES; RADIOPHARMACEUTICALS; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; YOUNG ADULT;

EID: 84862891292     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0269-4     Document Type: Article

References (44)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155:761-767 (Pubitemid 28252654)
2. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL et al (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97:8104-8109 (Pubitemid 30460780)
3. Andreasen NC (1999) A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. Arch Gen Psychiatry 56:781-787 (Pubitemid 29420698)
4. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC et al (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569-2574 (Pubitemid 27136916)
5. Bryan-Lluka LJ, Siebert GA, Pond SM (1999) Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn Schmiedebergs Arch Pharmacol 360:109-115 (Pubitemid 29420013)
6. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260 (Pubitemid 32385889)
7. Carlsson A, Waters N, Waters S, Carlsson ML (2000) Network interactions in schizophrenia - therapeutic implications. Brain Res Brain Res Rev 31:342-349 (Pubitemid 30136189)
8. Copolov DL, Seal ML, Maruff P, Ulusoy R, Wong MT, Tochon-Danguy HJ, Egan GF (2003) Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res 122:139-152 (Pubitemid 36412190)
9. de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D (2003) Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 160:303-309 (Pubitemid 41110456)
10. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF, Hahn K, Tatsch K (2000) Attention deficit hyperactivity disorder: binding of [99 mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27:1518-1524
11. Dresel S, Tatsch K, Dahne I, Mager T, Scherer J, Hahn K (1998) Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients. J Nucl Med 39:1138-1142 (Pubitemid 28326140)
12. Dresel SH, Kung MP, Huang X, Plossl K, Hou C, Shiue CY, Karp J, Kung HF (1999) In vivo imaging of serotonin transporters with [99 mTc]TRODAT-1 in nonhuman primates. Eur J Nucl Med 26:342-347 (Pubitemid 29176444)
13. Dresel SH, Kung MP, Huang XF, Plossl K, Hou C, Meegalla SK, Patselas G, Mu M, Saffer JR, Kung HF (1999) Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons. J Nucl Med 40:660-666 (Pubitemid 29171809)
14. Dresel SH, Kung MP, Plossl K, Meegalla SK, Kung HF (1998) Pharmacological effects of dopaminergic drugs on in vivo binding of [99 mTc]TRODAT-1 to the central dopamine transporters in rats. Eur J Nucl Med 25:31-39 (Pubitemid 28107901)
15. Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538-544
16. Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of firstepisode schizophrenia. Am J Psychiatry 157:514-520 (Pubitemid 30191189)
17. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276 (Pubitemid 18039085)
18. Kung HF (2001) Development of Tc-99 m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent. Nucl Med Biol 28:505-508 (Pubitemid 32539399)
19. Kung HF, Kasliwal R, Pan SG, Kung MP, Mach RH, Guo YZ (1988) Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide. J Med Chem 31:1039-1043
20. Kung HF, Kim HJ, Kung MP, Meegalla SK, Plossl K, Lee HK (1996) Imaging of dopamine transporters in humans with technetium-99 m TRODAT-1. Eur J Nucl Med 23:1527-1530 (Pubitemid 26379197)
21. la Fougere C, Krause J, Krause KH, Josef GF, Hacker M, Koch W, Hahn K, Tatsch K, Dresel S (2006) Value of 99mTc-TRO-DAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder. Nucl Med Commun 27:733-737 (Pubitemid 44213031)
22. Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvalahti E, Hietala J (2001) Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res 52:115-120 (Pubitemid 32947054)
23. Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451 (Pubitemid 30164887)
24. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS et al (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-9240
25. Ma KH, Huang WS, Chen CH, Lin SZ, Wey SP, Ting G, Wang SD, Liu HW, Liu JC (2002) Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. Nucl Med Biol 29:561-567 (Pubitemid 34667117)
26. Meegalla SK, Plossl K, Kung MP, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF (1997) Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J Med Chem 40:9-17 (Pubitemid 27027260)
27. Meegalla SK, Plossl K, Kung MP, Stevenson DA, Mu M, Kushner S, Liable-Sands LM, Rheingold AL, Kung HF (1998) Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents. J Med Chem 41:428-436 (Pubitemid 28093079)
28. Meisenzahl EM, Dresel S, Frodl T, Schmitt GJ, Preuss UW, Rossmuller B, Tatsch K, Mager T, Hahn K, Moller HJ (2000) D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. J Psychopharmacol 14:364-370 (Pubitemid 32059781)
29. Meisenzahl EM, Schmitt G, Grunder G, Dresel S, Frodl T, la Fougere C, Scheuerecker J, Schwarz M, Boerner R, Stauss J et al (2008) Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. Pharmacopsychiatry 41:169-175
30. Nyberg S, Farde L, Halldin C (1996) Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients. Psychiatry Res 67:163-171 (Pubitemid 26344748)
31. Nyberg S, Farde L, Halldin C, Dahl ML, Bertilsson L (1995) D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. Am J Psychiatry 152:173-178
32. Schmitt G (2000) Striatal dopamine transporter in drug-naive schizophrenic patients: A 99mTc-TRODAT-1-SPECT-Study. [Abstract] Europ Neuropsychopharmacol 10(3):324
33. Schmitt G (2001) Striatal dopaminergic synapses in drug naive schizophrenics. [Abstract] World J Biol Psychiatry 1:93S
34. Schmitt GJ, Frodl T, Dresel S, la Fougere C, Bottlender R, Koutsouleris N, Hahn K, Moller HJ, Meisenzahl EM (2006) Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 256:115-121
35. Schmitt GJ, la Fougere C, Dresel S, Frodl T, Hahn K, Moller HJ, Meisenzahl EM (2008) Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naive schizophrenic patients. Schizophr Res 101:133-141
36. Schmitt GJ, Meisenzahl EM, Dresel S, Tatsch K, Rossmuller B, Frodl T, Preuss UW, Hahn K, Moller HJ (2002) Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine. J Psychopharmacol 16:200-206 (Pubitemid 34983073)
37. Schmitt GJ, Meisenzahl EM, Frodl T, la Fougere C, Hahn K, Moller HJ, Dresel S (2005) The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. J Psychopharmacol 19:488-493 (Pubitemid 41392303)
38. Schmitt GJ, Meisenzahl EM, Frodl T, la Fougere C, Hahn K, Moller HJ, Dresel S (2009) Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT. Psychiatry Res 173:183-189
39. Siebert GA, Pond SM, Bryan-Lluka LJ (2000) Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells. Naunyn Schmiedebergs Arch Pharmacol 361:255-264 (Pubitemid 30106336)
40. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L et al (1995) A functional neuroanatomy of hallucinations in schizophrenia. Nature 378:176-179
41. Tauscher J, Kufferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S (2002) Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol. Psychopharmacology (Berl) 162:42-49 (Pubitemid 34639555)
42. Wright AM, Bempong J, Kirby ML, Barlow RL, Bloomquist JR (1998) Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia. Brain Res 788:215-222 (Pubitemid 28202164)
43. Yang YK, Yu L, Yeh TL, Chiu NT, Chen PS, Lee IH (2004) Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry 161:1496-1498 (Pubitemid 38989108)
44. Zipursky RB, Christensen BK, Daskalakis Z, Epstein I, Roy P, Furimsky I, Sanger T, Kapur S (2005) Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. Can J Psychiatry 50:462-469 (Pubitemid 43161799)